Research Article: Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation
Introduction:
Primary liver cancer (PLC) has emerged as a major public health threat, with increasing prevalence globally. It is estimated that more than one million patients will be diagnosed with PLC annually by . Hepatocellular carcinoma (HCC) accounts for more than % of PLC, causing about , deaths every year and ranking as the third leading cause of cancer death worldwide. HCC patients are treated based on tumor burden, liver function, and performance status. Liver transplantation, surgical resection, and ablation are…
Read more